His primary scientific interests are in Transplantation, Kidney transplantation, Surgery, Internal medicine and Kidney. His research investigates the connection with Transplantation and areas like Biopsy which intersect with concerns in Odds ratio. His research integrates issues of Urology, Regimen, Tacrolimus, Immunology and Plasmapheresis in his study of Kidney transplantation.
His work carried out in the field of Surgery brings together such families of science as Immunosuppression, Kidney disease and Renal function. His studies in Internal medicine integrate themes in fields like Gastroenterology and Diabetes mellitus. His research investigates the connection between Kidney and topics such as Urinary system that intersect with problems in ABO blood group system and Renal transplant.
The scientist’s investigation covers issues in Transplantation, Kidney transplantation, Surgery, Internal medicine and Kidney. His Transplantation research includes themes of Immunosuppression, Biopsy, Pathology and Urinary system. His studies deal with areas such as Kidney disease, Renal function, Urology, Immunology and Dialysis as well as Kidney transplantation.
The Renal function study combines topics in areas such as Creatinine and Blood pressure. His work in Internal medicine addresses subjects such as Gastroenterology, which are connected to disciplines such as Incidence. His Kidney research integrates issues from Inflammation, ABO blood group system and Pancreas.
Mark D. Stegall focuses on Kidney transplantation, Internal medicine, Transplantation, Kidney and Urology. His Kidney transplantation research is included under the broader classification of Surgery. His research integrates issues of Gastroenterology and Oncology in his study of Internal medicine.
His Transplantation research is multidisciplinary, incorporating elements of Diabetes mellitus, Clinical trial and ABO blood group system. His Kidney research includes elements of Pathology, Arteriosclerosis and Renal function. His Urology study incorporates themes from Type 1 diabetes, Glucose control and Glycemic.
His primary areas of investigation include Kidney transplantation, Transplantation, Internal medicine, Kidney and Surgery. His biological study spans a wide range of topics, including Urology, Nephropathy, Retrospective cohort study and Antibody, Isoantibodies. In his research on the topic of Transplantation, Clinical trial and Intensive care medicine is strongly related with Immunosuppression.
Mark D. Stegall has researched Internal medicine in several fields, including T cell and Oncology. He has included themes like Radiology and Histopathology in his Kidney study. Mark D. Stegall studied Surgery and Diabetes mellitus that intersect with Survival rate, Single Center and Survival analysis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Risk factors for primary dysfunction after liver transplantation--a multivariate analysis.
Rutger Ploeg;Anthony D'alessandro;Stuart Knechtle;Mark Stegall.
Transplantation (1993)
Identifying Specific Causes of Kidney Allograft Loss
Z. M. El-Zoghby;M. D. Stegall;D. J. Lager;W. K. Kremers.
American Journal of Transplantation (2009)
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
M. Haas;A. Loupy;C. Lefaucheur;C. Roufosse.
American Journal of Transplantation (2018)
Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients.
M. D. Stegall;T. Diwan;S. Raghavaiah;L. D. Cornell.
American Journal of Transplantation (2011)
A Comparison of Plasmapheresis Versus High-Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody
M.D. Stegall;J. Gloor;J.L. Winters;S.B. Moore.
American Journal of Transplantation (2006)
Measured and estimated GFR in healthy potential kidney donors.
Andrew D Rule;Hiie M Gussak;Gregory R Pond;Erik J Bergstralh.
American Journal of Kidney Diseases (2004)
The Association Between Age and Nephrosclerosis on Renal Biopsy Among Healthy Adults
Andrew D. Rule;Hatem Amer;Lynn D. Cornell;Sandra J. Taler.
Annals of Internal Medicine (2010)
New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation
Fernando G. Cosio;Yogish Kudva;Marije van der Velde;Timothy S. Larson.
Kidney International (2005)
Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production.
D. K. Perry;J. M. Burns;H. S. Pollinger;B. P. Amiot.
American Journal of Transplantation (2008)
Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody
J. M. Gloor;S. Sethi;M. D. Stegall;W. D. Park.
American Journal of Transplantation (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Johns Hopkins University
New York University
Mayo Clinic
Duke University
Cedars-Sinai Medical Center
University of Oxford
University of Minnesota
University of Leeds
South China Agricultural University
University of California, Irvine
Chinese Academy of Sciences
Zhengzhou University
University of British Columbia
Griffith University
Zhengzhou University
King's College London
Illinois State University
University of Santiago de Compostela
University of Michigan–Ann Arbor
Vrije Universiteit Amsterdam
Johns Hopkins University
Hastings Center